SUNNYVALE, Calif .– (COMMERCIAL THREAD) –NTT Research, Inc., a division of NTT (TYO: 9432), today announced the appointment of Joe Alexander, MD, Ph.D., as Director of Medical and Health Informatics Laboratory (MEI). Dr Alexander has been a Distinguished Scientist at the MEI Lab since February 2020. He succeeds Dr Hitonobu Tomoike, who holds the position of Professor-Researcher at the NTT Basic Research Lab in Japan. In his new role, Dr Tomoike will continue to advise all of NTT’s medical research activities. Dr Alexander, who took up his additional duties on June 1, 2021, joined NTT Research with an academic and pharmaceutical background to lead MEI Lab’s digital bio twins initiative, which initially focuses on the cardiovascular (CV) system. He will continue to lead the CV bio digital twin group while harmonizing the other MEI Lab projects as part of a global strategy that aligns with NTT Research and the NTT group at large.
“We are delighted that Dr Alexander has accepted this new challenge and delighted to see the MEI Lab continue to strive to achieve its ambitious goals under his leadership,” said Kazuhiro Gomi, President and CEO of NTT Research . “At the same time, we are grateful to Dr Tomoike for his role in founding and leading the MEI Lab during its first two years and look forward to working with him.
MEI Lab’s ongoing research is initially focused on multi-scale precision cardiology platforms such as the CV digital bio twin as well as heart-on-a-chip technology – aimed specifically at developing the infrastructure for a digital replica. from the heart of an individual. Such approaches draw on a wide range of sciences and technologies, including physiological control systems, hemodynamics, causal inference, modeling and simulation, and cardiovascular dynamics. In addition, through a joint research agreement together with the Neuroelectronics group at the Technical University of Munich (TUM), the MEI Lab is working on sensors and electrodes at the nano and micro scale. Related research focuses on actuators, 3D transformable electrodes, biocompatible materials, and other organ-on-chip microfluidic technologies. Wearable and remote sensing devices also continue to be of particular interest as these technologies evolve and mature to support future bionumeric twin applications.
“It is an honor to follow in Dr Tomoike’s footsteps and continue to advance our lab’s ambitious ‘moonshot’ goals,” said Dr Alexander. “One of my initial goals will be to support the in-depth work of all MEI Lab members for strategically aligned projects. In the future, I also intend to look for ways to go further and better position ourselves within NTT Research and the NTT Group in general, particularly in the context of healthcare.
Prior to joining NTT Research, Dr. Alexander spent 18 years with Pfizer, Inc., where he most recently served as Senior Medical Director, Global Medical Affairs. At Pfizer, he has worked in the areas of cardiovascular medicine, clinical imaging and measurement technologies worldwide, medical devices and pulmonary hypertension, and has regularly conducted research in modeling and simulation. in several of these areas. Previously, he worked for two years at Merck, Inc. and spent eight years at Vanderbilt University, where he completed a two-year residency in internal medicine and was professor of medicine and biomedical engineering. Dr Alexander received his MD and PhD. (Biomedical Engineering) at Johns Hopkins University School of Medicine.
The momentum within the MEI Lab has grown significantly over the past year. In June 2021, Iris shelly, an applied research engineer with expertise in biomedical signal processing and low power devices, joined the MEI Lab as a scientist. In February 2021, NTT Research announced that the MEI Lab had entered a joint research agreement with the National Cerebral and Cardiovascular Center (NCVC) of Japan to develop computational models related to cardiovascular disease, implement them on a bionumeric twin platform, and develop applications for physicians and patients. In November 2020, Dr. Jon peterson, a biomedical engineer with a deep understanding of cardiovascular physiology, joined the MEI lab as a senior scientist.
As it advances into next-generation medical diagnostics and therapies, the MEI Lab’s CV bionumeric twin research also offers opportunities for synergy between the other two NTT research labs. Among the areas explored in the Cryptography and Information Security Laboratory (CIS), for example, are techniques that calculate data that remains encrypted and private. the Physics and Computer Science Laboratory (PHI), meanwhile, is engaged in work on quantum information systems, an application of which could lead to the solution of combinatorial optimization problems that advance the discovery of new drugs.
About NTT Research
NTT Research opened its offices in July 2019 as a new Silicon Valley startup to conduct fundamental research and advance technologies that drive positive change for humanity. Currently, three laboratories are housed at NTT Research’s facilities in Sunnyvale: the Physics and Informatics Laboratory (PHI), the Cryptography and Information Security Laboratory (CIS), and the Medical Informatics and Computing Laboratory. health (MEI). The organization aims to improve reality in three areas: 1) quantum information, neuroscience and photonics; 2) cryptographic and information security; and 3) medical and health informatics. NTT Research is part of NTT, a global provider of technology and business solutions with an annual R&D budget of $ 3.6 billion.
NTT and the NTT logo are registered trademarks or trademarks of NIPPON TELEGRAPH AND TELEPHONE CORPORATION and / or its affiliates. All other product names referenced are trademarks of their respective owners. © 2021 NIPPON TELEGRAPH AND TELEPHONE CORPORATION